Pfizer Says Eczema Drug Shows Significant Skin Clearance
Pfizer reports positive Phase 2 trial results for tilrekimig in treating moderate-to-severe atopic dermatitis at the EADV Congress.
Share
Why It Matters
Pfizer tested a new eczema medicine and it worked really well on skin. When a company's medicine works in testing, people watch to see if it becomes real.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.